Related references
Note: Only part of the references are listed.TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis
Kari Rostad et al.
APMIS (2009)
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer
Sameer Jhavar et al.
BJU INTERNATIONAL (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
Juan-Miguel Mosquera et al.
CLINICAL CANCER RESEARCH (2009)
ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2009)
Distinct Genomic Aberrations Associated with ERG Rearranged Prostate Cancer
Francesca Demichelis et al.
GENES CHROMOSOMES & CANCER (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
ETS gene fusions in prostate cancer
Jeremy P. Clark et al.
NATURE REVIEWS UROLOGY (2009)
N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer
Dorothee Pflueger et al.
NEOPLASIA (2009)
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer:: implications for tissue-based diagnostics
G. Kristiansen et al.
BRITISH JOURNAL OF CANCER (2008)
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
G. Attard et al.
BRITISH JOURNAL OF CANCER (2008)
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations:: Identification of DDX5-ETV4 fusion protein in prostate cancer
Bo Han et al.
CANCER RESEARCH (2008)
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer
Bharathi Laxman et al.
CANCER RESEARCH (2008)
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
Sunita R. Setlur et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
A causal role for ERG in neoplastic transformation of prostate epithelium
Olga Klezovitch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
TMPRSS2-ERG fusion heterogeneity in Multifocal prostate cancer: Clinical and biologic implications
Marc Barry et al.
UROLOGY (2007)
Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer
Daphne Hessels et al.
CLINICAL CANCER RESEARCH (2007)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
TMPRSS2-ERG fusion prostate cancer:: An early molecular event associated with invasion
Sven Perner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Morphological features of TMPRSS2-ERG gene fusion prostate cancer
J-M Mosquera et al.
JOURNAL OF PATHOLOGY (2007)
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
Rohit Mehra et al.
MODERN PATHOLOGY (2007)
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer
Bharathi Laxman et al.
NEOPLASIA (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
25-year prostate cancer control and survival outcomes: A 40-year radical prostatectomy single institution series
Christopher R. Porter et al.
JOURNAL OF UROLOGY (2006)
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
Jack Groskopf et al.
CLINICAL CHEMISTRY (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer
D Hessels et al.
EUROPEAN UROLOGY (2003)
New targets for therapy in prostate cancer: Differential display code 3 (DD3(PCA3)) a highly prostate cancer-specific gene
JA Schalken et al.
UROLOGY (2003)